$32.91
1.76%
NYSE, Oct 07, 04:03 pm EDT. Closed.
ISIN
US6877931096
Symbol
OSCR
Sector
Industry

Oscar Health Target price 2026 - Analyst rating & recommendation

Oscar Health Classifications & Recommendation

Buy
47%
Hold
47%
Sell
5%

Oscar Health Price Target

Target Price $30.60
Price $32.34
Deviation
Number of Estimates 15
15 Analysts have issued a price target Oscar Health 2027 . The average Oscar Health target price is $30.60. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 19 analysts: 9 Analysts recommend Oscar Health to buy, 9 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Oscar Health stock has an average upside potential 2027 of . Most analysts recommend the Oscar Health stock at Buy or hold.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 11.70 19.13
27.50% 63.48%
EBITDA Margin -3.14% 4.24%
422.35% 235.02%
Net Margin -3.79% 2.98%
1,466.76% 178.69%

14 Analysts have issued a sales forecast Oscar Health 2026 . The average Oscar Health sales estimate is

$19.1b
unlock
. This is
24.87% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$19.8b 29.21%
unlock
, the lowest is
$18.0b 17.56%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $11.7b 27.50%
2026
$19.1b 63.48%
unlock
2027
$20.8b 8.83%
unlock
2028
$23.0b 10.38%
unlock
2029
$25.8b 12.36%
unlock
2030
$28.8b 11.52%
unlock

15 Analysts have issued an Oscar Health EBITDA forecast 2026. The average Oscar Health EBITDA estimate is

$812m
unlock
. This is
23.41% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$892m 35.58%
unlock
, the lowest is
$674m 2.49%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-367m 510.99%
2026
$812m 320.98%
unlock
2027
$998m 22.85%
unlock
2028
$1.4b 38.14%
unlock
2029
$1.2b 11.97%
unlock

EBITDA Margin

2025 -3.14% 422.35%
2026
4.24% 235.02%
unlock
2027
4.79% 12.97%
unlock
2028
6.00% 25.26%
unlock
2029
4.70% 21.67%
unlock

15 Oscar Health Analysts have issued a net profit forecast 2026. The average Oscar Health net profit estimate is

$569m
unlock
. This is
3.39% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$687m 24.74%
unlock
, the lowest is
$281m 48.93%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-443m 1,842.63%
2026
$569m 228.49%
unlock
2027
$684m 20.21%
unlock
2028
$898m 31.13%
unlock
2029
$825m 8.11%
unlock
2030
$888m 7.63%
unlock

Net Margin

2025 -3.79% 1,466.76%
2026
2.98% 178.69%
unlock
2027
3.29% 10.40%
unlock
2028
3.91% 18.84%
unlock
2029
3.19% 18.41%
unlock
2030
3.08% 3.45%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -1.69 1.84
1,790.00% 208.88%
P/E 17.53
EV/Sales 0.32

15 Analysts have issued a Oscar Health forecast for earnings per share. The average Oscar Health EPS is

$1.84
unlock
. This is
11.52% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$2.23 35.15%
unlock
, the lowest is
$0.91 44.85%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-1.69 1,790.00%
2026
$1.84 208.88%
unlock
2027
$2.22 20.65%
unlock
2028
$2.91 31.08%
unlock
2029
$2.67 8.25%
unlock
2030
$2.88 7.87%
unlock

P/E ratio

Current 19.60 157.01%
2026
17.53 10.56%
unlock
2027
14.58 16.83%
unlock
2028
11.12 23.73%
unlock
2029
12.10 8.81%
unlock
2030
11.24 7.11%
unlock

Based on analysts' sales estimates for 2026, the Oscar Health stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.40 29.03%
2026
0.32 20.20%
unlock
2027
0.29 8.11%
unlock
2028
0.27 9.41%
unlock
2029
0.24 10.99%
unlock
2030
0.21 10.32%
unlock

P/S ratio

Current 0.64 21.91%
2026
0.51 19.92%
unlock
2027
0.47 8.12%
unlock
2028
0.42 9.40%
unlock
2029
0.38 11.01%
unlock
2030
0.34 10.33%
unlock

Current Oscar Health Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Raymond James
Locked
➜
Locked
Locked Sep 18 2026
Barclays
Locked
➜
Locked
Locked Sep 17 2026
B of A Securities
Locked
➜
Locked
Locked Sep 17 2026
Baird
Locked
➜
Locked
Locked Sep 17 2026
Stephens & Co.
Locked
➜
Locked
Locked Sep 17 2026
Wells Fargo
Locked
➜
Locked
Locked Aug 13 2026
Barclays
Locked
➜
Locked
Locked Aug 07 2026
Analyst Rating Date
Locked
Raymond James:
Locked
➜
Locked
Sep 18 2026
Locked
Barclays:
Locked
➜
Locked
Sep 17 2026
Locked
B of A Securities:
Locked
➜
Locked
Sep 17 2026
Locked
Baird:
Locked
➜
Locked
Sep 17 2026
Locked
Stephens & Co.:
Locked
➜
Locked
Sep 17 2026
Locked
Wells Fargo:
Locked
➜
Locked
Aug 13 2026
Locked
Barclays:
Locked
➜
Locked
Aug 07 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today